Next Article in Journal
The Perspective of the General Population in Saudi Arabia towards Do-Not-Resuscitate (DNR) Orders: A Cross-Sectional Study
Next Article in Special Issue
Basic Health Service Delivery to Vulnerable Populations in Post-Conflict Eastern Congo: Asset Mapping
Previous Article in Journal
Determination of the Frequency of Migraine Attacks in Pregnant Women and the Ways They Cope with Headaches: A Cross-Sectional Study
Previous Article in Special Issue
Social Experiences, Discrimination, and Violence among Men Who Have Sex with Men in a Northern Brazilian Capital
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil

by
Helena Fiats Ribeiro
1,*,
Maria Dalva de Barros Carvalho
1,
Fernando Castilho Pelloso
2,
Lander dos Santos
1,
Marcela de Andrade Pereira Silva
1,
Kely Paviani Stevanato
1,
Deise Helena Pelloso Borghesan
3,
Isaac Romani
3,
Vlaudimir Dias Marques
1,
Karina Maria Salvatore de Freitas
3,
Ana Carolina Jacinto Alarcão
1,
Constanza Pujals
1,
Raíssa Bocchi Pedroso
1,
Alexandrina Aparecida Maciel Cardelli
4 and
Sandra Marisa Pelloso
1
1
Health Sciences Center, State University of Maringá-UEM, Maringá 87020-900, Brazil
2
Medicine Centers, Federal University of Paraná-UFPR, Curitiba 80060-240, Brazil
3
University Center UNINGÁ, Maringá 87035-510, Brazil
4
Department of Graduate Studies in Nursing, State University of Londrina, Londrina 86057-970, Brazil
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(14), 2072; https://doi.org/10.3390/healthcare11142072
Submission received: 1 June 2023 / Revised: 30 June 2023 / Accepted: 16 July 2023 / Published: 20 July 2023

Abstract

:
Background: This study aimed to analyze maternal risk factors associated with negative outcomes of COVID-19 and association with socioeconomic indicators in Brazil. Methods: A cross-sectional study, with data from the Influenza Epidemiological Surveillance Information System (SIVEP-Flu) of pregnant women with COVID-19 and cases of hospitalization and death. For the analysis of risk factors and outcomes, the multiple logistic regression method was used. Results: Pregnant women who had some risk factor represented 47.04%. The chance of death was 2.48 times greater when there was a risk factor, 1.55 for ICU admission and 1.43 for use of ventilatory support. The percentage of cure was 79.64%, 15.46% without any negative outcome, 4.65% death and 0.26% death from other causes. Pregnant women who did not take the vaccine represented 30.08%, 16.74% took it and 53.18% were not specified. The variables HDI, illiteracy, per capita income and urbanization did not influence the cases of COVID-19. Conclusions: Factors such as age, obesity, asthma and pregnancy were responsible for the increase in hospitalizations, respiratory complications and death. Vaccination reduced the risk of negative outcomes by 50%. There were no correlations between socioeconomic indicators and the negative outcomes of COVID-19 in pregnant women.

1. Introduction

The association between COVID-19 and pregnancy was ruled out at the beginning of the pandemic, but recent studies have shown that pregnant and postpartum women are more susceptible to adverse outcomes resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1,2]. Research indicates that pregnant women with COVID-19 infections have high rates of hospitalization, mechanical ventilation, admission to the intensive care unit (ICU) and premature birth [3].
During pregnancy, several changes occur in the physiological and immune system that increase the risks of COVID-19 infection. The number of cases of maternal morbidity and mortality associated with the virus has increased since the beginning of the pandemic [4]. A study carried out in the United States in March 2020, with 43 hospitalized pregnant women, identified that 30% of them required admission to an intensive care unit (ICU), 14% required mechanical ventilation and one died from COVID-19 [5]. In Brazil, the mortality rate among pregnant and postpartum women due to COVID-19 reached the milestone of 12.7% in 2020, representing the highest rate in the world ranking [6].
Studies have shown that in developing countries with low- and middle-income characteristics, maternal risks for COVID-19 are increased. These countries tend to have aspects that contribute negatively to the care of the obstetric population, such as: poor distribution of physical and human resources, lack of adequate containment measures, high birth rates and inefficient prenatal care [6,7,8].
In addition, a 29% higher mortality rate was found in regions with non-working and non-white residents, compared to areas with white residents and permanent jobs. As a result, the geographic area of residence and the socioeconomic status of the population may result in a propensity for increased mortality and morbidity from COVID-19 [9,10,11].
Takemoto et al. (2020) [6] provided information regarding risk factors in pregnant women with COVID-19 with negative outcomes in 2020. Significant conditions associated with COVID-19 infected pregnant women arose after that, indicating the need for an update of these risk factors and the search for a correlation of these risk factors and socioeconomic indicators.
It is noteworthy that the COVID-19 pandemic highlighted existing flaws in the Brazilian healthcare system, such as obstetric care being beset by chronic problems that can affect maternal and perinatal outcomes, such as poor-quality antenatal care, insufficient resources to manage emergency and critical care, racial disparities in access to maternity services and obstetric violence [6]. It is hypothesized that there is a direct relationship between healthcare and access indicators and economic or social inequalities faced by the population [12].
For this reason, the main objective of this study was to analyze maternal risk factors associated with negative outcomes of COVID-19 and their relation to socioeconomic indicators in the states of Brazil.

2. Materials and Methods

This is a cross-sectional study with secondary data from confirmed maternal cases of COVID-19 in Brazil, from July 2020 to April 2022. The selection criteria for analysis included all pregnant women with confirmed SARS-CoV-2 infection (RT-PCR or serological test), regardless of the outcome (death or cure), recorded from July 2020 to April 2022. The database had 23,580 samples, collected in all states of Brazil.

2.1. Data Collection

For the analysis of variables related to risk factors (heart disease, hematological disease, Down syndrome, liver disease, asthma, diabetes, neurological disease, lung disease, kidney disease, immunosuppression and obesity) and outcomes (death, ICU stay and ventilatory support) associated with socioeconomic indicators (illiteracy, income, degree of urbanization and Human Development Index), the method of multiple logistic regression was used, with 95% confidence interval. The level of statistical significance was set at 0.05.
The R software (R Core Team (2021)) was used for data processing (R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/ (accessed on 20 September 2022)), where descriptive statistics, Pearson’s correlation tests and regression models presented in graphs were produced.
Pearson’s correlation test was applied to two variables to verify the degree of correlation between them, which is the impact force that one is capable of causing on the other. Such strength is represented by means of ρ, which varies between −1 and 1, also indicating the direction of the correlation. If p < 0, it indicates that the correlation between the variables is negative (while one increases, the other decreases). If ρ > 0, it indicates that the growth of one impacts on the growth of the other. When ρ = 0, it means that there is no correlation between the variables. ρ = 1 or ρ = −1 indicates perfect correlation (positive or negative).
The correlation test was performed based on the hypothesis of a positive correlation between the variables.
To perform the analysis, the logistic regression model of the binomial family was considered. This model considers the relationship of a binary dependent variable (1 or 0) with one or more independent variables. When using the response variables (ICU, ventilatory support and death), it was considered that 1 indicates that the patient presented the response and 0 indicates that they did not.
The equation for the applied logistic regression model is written as:
p = 11 + e-b0 + b1 × 1 + ... + bkxk
where bk are the regression coefficients and xk are the explanatory variables.
Poisson regression is more suitable when the data of the response variable are countable, meaning the number of times that a certain situation occurred.
The equation for the Poisson regression model can be written in the form:
EY = exp0 + exp1Wi
where Wi refers to the covariate considered in the i-th observation.

2.2. Ethical Aspects

The study followed all ethical norms in accordance with Resolution 466/CNS 2012 and was approved by the Ethics Committee for Research with Human Beings of the Centro Universitário Ingá/Uningá under opinion No. 5.048.027, in the year 2021.

3. Results

The total number of cases reported from July 2020 to April 2022 was 23,580, amongst which 5.68% were identified as postpartum women and 94.32% as pregnant women. Most pregnant women (59.11%) were in the 3rd trimester of pregnancy, 24.92% in the 2nd trimester and 10.79% in the 1st trimester. Regarding race, 45.48% of pregnant women were brown, 34.79% white, 5.9% black and 0.73% East Asian or native born. The majority (83.11%) lived in urban areas, 6.65% in rural areas and 0.48% in suburban areas. The average age of pregnant women was 28.9 years. Among pregnant women, it was also found that 30.08% had not taken the vaccine and only 16.74% had. When the risk factors were analyzed, 47.04% of the pregnant women had had at least one of them.
Among the risk factors, 5.25% had heart disease, 0.48% chronic hematologic disease, 0.08% Down syndrome, 0.22% liver disease, 4.62% asthma, 6.46% diabetes, 0.66% neurological problems, 0.75% lung disease, 1.07% immunosuppression, 0.56% kidney disease, 4.06% obesity and 30.85% had other risk factors such as smoking, high blood pressure or pregnancy itself as a risk factor.
Regarding the outcome, 79.64% were cured, 15.46% did not have any specified outcome, 4.65% died from the disease and 0.26% died from other causes. The average HDI was 0.75. The average illiteracy rate was 8.66% and the urbanization rate was around 80%. The average per capita income identified among the states was BRL 1187.07 (Table 1).
As for the symptoms of pregnant women with COVID-19, most had fever (51.6%) and cough (65.27%). Alternative symptoms were recorded such as: dyspnea (49.3%); respiratory discomfort (38.99%); low saturation (31.29%); sore throat (21.76%) and other undetermined symptoms (43.23%). Diarrhea and vomiting were less frequent symptoms, recorded in only 9.27% and 10.14% of the sample, respectively.
No significant p-values were found (α < 0.05), indicating that the HDI, the illiteracy rate, per capita income and the urbanization rate are capable of influencing the negative outcomes of cases of COVID-19 in pregnant women who had risk factors (Table 2) (Figures S1–S4).
Among the pregnant women who had risk factors, the negative outcomes analyzed were “death”, “ICU admission” and “ventilatory support”. For the death response variable, the risk factors that influenced it the most were diabetes, obesity and age. Based on the odds ratio, patients with diabetes were 1.61 times more likely to die than a pregnant woman who did not have the disease. The same occurred with pregnant women who were obese, with a 2.93 times greater chance of death. In addition, patients aged over 35 years were 1.92 times more likely to die compared to patients aged up to 35 years (Table 3).
For the response variable “ICU admission”, among pregnant women with risk factors, obesity and age were the ones that influenced the chance of ICU admission. Pregnant women who had heart disease were 1.4 times more likely to be hospitalized. Asthma increased the chance of hospitalization by 1.48 times, compared to those who did not have it. In addition, obesity was shown to be a factor that increased the chance of hospitalization by 3 times in pregnant women who had it. Patients aged over 35 years were 1.43 times more likely to be admitted to the ICU (Table 3).
For the response variable “need for ventilatory support” among pregnant women with risk factors, the adjusted logistic model indicates that factors such as race, education, heart disease, asthma, obesity and age interfered with the chances of needing ventilatory support. Illiteracy could increase the chance that pregnant women would use respiratory support by 3.11 times. The chance of using ventilatory support was increased by 1.52 times for pregnant women with heart disease, and those with asthma had a 2.08-fold increase. It was also verified that the obesity risk factor leads to a 2.42 times greater chance of needing such a resource. In this case, patients older than 35 years are 1.72 times more likely to need ventilatory support than patients younger than 35 years (Table 3).
Among the data about the location of housing and hospitalization of pregnant women, the Federal District (74.79%) was the place responsible for the largest number of pregnant women who needed to travel to undergo treatment for COVID-19, followed by by Roraima (61.76%), Pernambuco (59.06%) and Espírito Santo (51.49%). In more than 50% of cases of COVID-19 in pregnant women, the location of housing and treatment of pregnant women did not match, requiring their displacement to receive the necessary treatment. In Amapá, 83.33% of pregnant women were able to undergo treatment in the same region. This percentage was 82.33% in Amazonas and 74.08% in Mato Grosso do Sul (Figure 1).
Regarding the number of doctors, nurses and beds per 100,000 inhabitants, it was noted that the Federal District was the region with the most doctors per 100,000 inhabitants, as well as one of the regions with the highest number of nurses and available beds. Despite this, this region had one of the lowest prevalence of hospitalizations for pregnant women residing there (only 5 cases per 100,000 inhabitants). The same occurred in São Paulo, Rio de Janeiro, Rio Grande do Sul, Minas Gerais and Espírito Santo, states with a large number of doctors and nurses, but with low rates of care for pregnant women residing there. On the other hand, Amapá and Amazonas are among the states with fewer physicians but with more care for pregnant women in their respective cities (around 14 per 100,000 inhabitants) (Figure 2).

4. Discussion

This study analyzed the risk factors and negative outcomes of COVID-19 in pregnant women and their association with socioeconomic indicators of the Brazilian states. The data showed that factors such as age, obesity, asthma and pregnancy actually contributed to the increase in chances of hospitalizations, respiratory complications and even death in the presence of COVID-19. Previous studies [8,12] with pregnant and postpartum women who had comorbidities and risk factors also presented higher odds of adverse outcomes from COVID-19.
The main risk factors raised among pregnant women are the ones that increase the chances of a near miss or morbidity. Factors such as chronic hematological disease, Down syndrome, liver disease, neurological disease, immunosuppression, kidney diseases and smoking were not significant in relation to the negative outcomes of COVID-19. An analysis carried out in Mexico [13] identified that pregnant women who had comorbidities, including hypertension, respiratory system diseases and cardiovascular diseases, especially diabetes, had an increased chance of dying from COVID-19.
Risk factors such as diabetes were considered relevant for the increase in death probability by 2.78 times, confirming the direct relationship between the presence of diabetes and adverse outcomes in pregnant women with COVID-19. In a study carried out with 1241 pregnant women in 2020, this association was due to the increase in cases of non-communicable diseases in women of childbearing age [14].
Another risk factor, obesity, may be responsible for the increase in negative outcomes, as problems such as diabetes and hypertension result from it. In addition, there are indications that overweight and obesity are associated with an increased risk of prenatal maternal morbidity [15].
Among the comorbidities and other risk factors of pregnant women for the variables death, ICU stay and ventilatory support, there was an association with advanced maternal age. Pregnant women over 35 years old had a greater chance of comorbidities and clinical complications, because as age advances, the chance of pre-existing comorbidities manifesting also increases proportionally. Therefore, the importance of preconception assessments as a strategy to prevent adverse outcomes in this population of women with advanced maternal age should be reinforced [16,17].
Historically in Brazil, hypertension has been the comorbidity most associated with obstetric outcomes such as near misses and maternal death [11,18]. The findings of this research confirmed that the presence of both various cardiovascular diseases and hypertension in pregnant women, described as “cardiopathies”, was a contributing factor to maternal outcomes such as death, ICU stay and use of ventilatory support. Pregnant women who experience hypoxemia are 20% more likely to die. Hypoxemia can be derived both from conditions such as asthma and from other unspecified pneumopathies [19]. Furthermore, the need to use ventilatory support reached high rates among pregnant women infected with COVID-19, demonstrating the severity of the disease.
This study showed that vaccination was able to reduce the risk of all negative outcomes by 50%. Specifically, vaccination coverage against COVID-19 in this population reduced the negative outcome death by more than half. A study in Brazil revealed that vaccinated people were significantly less likely to need ventilatory support and invasive ventilation compared to unvaccinated people. Therefore, the COVID-19 vaccine may help pregnant women with the disease [20].
No correlations were found between socioeconomic indicators (HDI, illiteracy rate, per capita income and urbanization rate) and COVID-19 outcomes. However, an increase in per capita income increased the chance of ICU admission, perhaps due to the size of the population in the region. This study demonstrated that areas with higher income were a risk factor for the chance of ICU admission. Income inequality can result in more serious consequences for COVID-19. Large cities in Brazil have better infrastructure and resources to receive serious cases of COVID-19, so pregnant women living in areas with greater social vulnerability not only have barriers to accessing health and emergency care but also lack access to housing, transportation and education [21,22].
Although, in the present study, no associations were found between socioeconomic indicators and cases of COVID-19 in pregnant women, these data differ from other studies carried out previously, where groups of people with better or worse health conditions reflected different exposure to health risks associated with factors such as socioeconomic conditions [23]. In an evaluation carried out by the WHO in 2016, it was identified that high poverty and low education have been related to precarious access to health services [24].
Also, in opposition to the findings of the present study, in two other ones carried out in Brazil, it was verified that cases of COVID-19 in the obstetric population have high mortality rates in regions with high socioeconomic deprivation and poor infrastructure of health services [19,25].
The discrepancy between the results of this study and other studies carried out previously can be explained by two reasons. First, in one of the cited studies [25] the size of the analyzed sample was significantly smaller than the sample of this study, which might have led to divergences in the results. Second, the methods used in other studies [19,25] to confirm the association of negative COVID-19 results in obstetric populations differ from those applied in this study. Those authors described only the methodology applied in the analysis whereas the socioeconomic indicators were not specified, suggesting that such an analysis was not carried out, contrary to the methodology applied in this study.
It is necessary to reinforce public policy measures aimed at the obstetric population, with the aim of breaking down barriers to access to care. Future studies may include poor areas where access to health services with laboratory facilities is not available. Consequently, it could help to understand the low or absent rates of detection in poor areas.

5. Limitations

This study has limitations such as the data analyzed coming from secondary data, which may present failures in recording, resulting in possibilities of bias due to missing variables. However, the health information systems of the Brazilian Ministry of Health are commonly used as a source of data for various surveys, as well as contribute to the planning of health policies and programs. In addition, during the COVID-19 pandemic, SIVEP-Flu was a source of data in the country.

6. Conclusions

Adverse outcomes in Brazilian pregnant women infected with COVID-19 are affected by clinical characteristics and comorbidities. Therefore, it is necessary to reinforce the importance of precautionary measures against COVID-19 and the performance of quality prenatal care. Vaccination in this population can reduce the chance of death and respiratory complications by up to 50%. Although no correlations were identified between socioeconomic indicators and cases of COVID-19 in this study, it is important to emphasize the importance of health interventions aimed at the populations with social and economic vulnerability, since they have been proving to be more fragile in studies carried out over the last few years.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/healthcare11142072/s1, Figure S1: Poisson model adjusted to the points of incidence of COVID-19 cases in pregnant women by the HDI of the state. Figure S2: Poisson model adjusted to points of incidence of COVID-19 cases in pregnant women by state illiteracy rate. Figure S3: Poisson model adjusted to points of incidence of COVID-19 cases in pregnant women by per capita income in the state. Figure S4: Poisson model adjusted to points of incidence of COVID-19 cases in pregnant women by state urbanization rate.

Author Contributions

Conceptualization, H.F.R. and S.M.P.; methodology, H.F.R. and S.M.P.; software, H.F.R.; validation, H.F.R., S.M.P., A.A.M.C. and M.D.d.B.C.; formal analysis, H.F.R.; investigation, K.P.S.; resources, M.d.A.P.S. and C.P.; data curation, L.d.S.; writing—original draft preparation, H.F.R.; writing—review and editing, D.H.P.B., I.R., V.D.M., K.M.S.d.F., A.C.J.A. and R.B.P.; visualization, F.C.P.; supervision, H.F.R. and S.M.P.; project administration, H.F.R. and S.M.P.; funding acquisition, H.F.R. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES) (financial code 001).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Comitê de Ética em Pesquisas com Seres Humanos do Centro Universitário Ingá/Uningá (protocol code 5.048.027, October 2021 date of approval).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are publicly available.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wiersinga, W.J.; Rhodes, A.; Cheng, A.C.; Peacock, S.J.; Prescott, H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020, 324, 782–793. [Google Scholar] [CrossRef] [PubMed]
  2. Lokken, E.M.; Walker, C.L.; Delaney, S.; Kachikis, A.; Kretzer, N.M.; Erickson, A.; Resnick, R.; Vanderhoeven, J.; Hwang, J.K.; Barnhart, N.; et al. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am. J. Obstet. Gynecol. 2020, 223, 911.e1–911.e14. [Google Scholar] [CrossRef] [PubMed]
  3. Lokken, E.M.; Huebner, E.M.; Taylor, G.G.; Hendrickson, S.; Vanderhoeven, J.; Kachikis, A.; Coler, B.; Walker, C.L.; Sheng, J.S.; Al-Haddad, B.J.; et al. Disease Severity, Pregnancy Outcomes and Maternal Deaths among Pregnant Patients with SARS-CoV-2 Infection in Washington State. Am. J. Obstet. Gynecol. 2021, 225, 77.e1–77.e14. [Google Scholar] [CrossRef] [PubMed]
  4. Allotey, J.; Fernandez, S.; Bonet, M.; Stallings, E.; Yap, M.; Kew, T.; Zhou, D.; Coomar, D.; Sheikh, J.; Lawson, H.; et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ 2020, 370, 3320. [Google Scholar] [CrossRef] [PubMed]
  5. Panagiotakopoulos, L. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics—Eight U.S. Health Care Centers, March 1–May 30, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 1355–1359. [Google Scholar] [CrossRef]
  6. Takemoto, M.L.; Menezes, M.D.O.; Andreucci, C.B.; Nakamura-Pereira, M.; Amorim, M.M.; Katz, L.; Knobel, R. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int. J. Gynecol. Obstet. 2020, 51, 154–156. [Google Scholar] [CrossRef]
  7. Amorim, M.M.R.; Soligo Takemoto, M.L.; da Fonseca, E.B. Maternal deaths with coronavirus disease 2019: A different outcome from low- to middle-resource countries? Am. J. Obstet. Gynecol. 2020, 223, 298–299. [Google Scholar] [CrossRef]
  8. Takemoto, M.L.; Menezes, M.O.; Andreucci, C.B.; Knobel, R.; Sousa, L.A.; Katz, L.; Fonseca, E.B.; Magalhães, C.G.; Oliveira, W.K.; Rezende-Filho, J.; et al. Maternal mortality and COVID-19. J. Matern.-Fetal Neonatal Med. 2020, 35, 2355–2361. [Google Scholar] [CrossRef]
  9. Joseph, N.; Wylie, B. Maternal deaths in Brazil from severe COVID-19 respiratory disease: Time for a global commitment to ending health disparities. BJOG Int. J. Obstet. Gynaecol. 2020, 127, 1627. [Google Scholar] [CrossRef]
  10. Roberton, T.; Carter, E.D.; Chou, V.B.; Stegmuller, A.R.; Jackson, B.D.; Tam, Y.; Sawadogo-Lewis, T.; Walker, N. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: A modelling study. Lancet Glob. Health 2020, 8, 901–908. [Google Scholar] [CrossRef]
  11. Nakamura-Pereira, M.; Amorim, M.M.R.; Pacagnella, R.D.C.; Takemoto, M.L.S.; Penso, F.C.C.; Rezende-Filho, J.D.; Leal, M.D.C. COVID-19 and Maternal Death in Brazil: An Invisible Tragedy. Rev. Bras. Ginecol. Obs. RBGO Gynecol. Obstet. 2020, 42, 445–447. [Google Scholar] [CrossRef] [PubMed]
  12. Menezes, M.O.; Takemoto ML, S.; Nakamura-Pereira, M.; Katz, L.; Amorim MM, R.; Salgado, H.O.; Melo, A.; Diniz CS, G.; de Sousa LA, R.; Magalhaes, C.G.; et al. Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil. Int. J. Gynecol. Obstet. 2020, 151, 415–423. [Google Scholar] [CrossRef] [PubMed]
  13. Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.; Wang, H.; Wang, Y.; Zhou, Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [Google Scholar] [CrossRef] [PubMed]
  14. Martinez-Portilla, R.J.; Sotiriadis, A.; Torres-Torres, J.; Christos, C.; Hawkins-Villarreal, A.; Villafan-Bernal, J.R.; Gurrola-Ochoa, R.A.; Figueras, F. Risk factors for mortality in pregnant women with SARS-CoV-2 infection. medRxiv 2020. [Google Scholar] [CrossRef]
  15. Siddiqui, A.; Azria, E.; Howell, E.A.; Deneux-Tharaux, C.; Langer, B.; Dupont, C.; Seco, A. Associations between maternal obesity and severe maternal morbidity: Findings from the French EPIMOMS population-based study. Paediatr. Perinat. Epidemiol. 2018, 33, 7–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Claramonte Nieto, M.; Meler Barrabes, E.; Garcia Martínez, S.; Gutiérrez Prat, M.; Serra Zantop, B. Impact of aging on obstetric outcomes: Defining advanced maternal age in Barcelona. BMC Pregnancy Childbirth 2019, 19, 342. [Google Scholar] [CrossRef]
  17. Suleyman, G.; Fadel, R.A.; Malette, K.M.; Hammond, C.; Abdulla, H.; Entz, A.; Demertzis, Z.; Hanna, Z.; Failla, A.; Dagher, C.; et al. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA Netw. Open 2020, 3, 2012270. [Google Scholar] [CrossRef]
  18. Brasil. Ministério da Saúde. Departamento de Informática do Sistema Único de Saúde (DATASUS). Sistema de Informações sobre Mortalidade (SIM). 2019. Available online: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obt10uf.def (accessed on 29 November 2022).
  19. Siqueira, T.S.; de Souza, E.K.G.; Martins-Filho, P.R.; Silva, J.R.S.; Gurgel, R.Q.; Cuevas, L.E.; Santos, V.S. Clinical characteristics and risk factors for maternal deaths due to COVID-19 in Brazil: A nationwide population-based cohort study. J. Travel Med. 2022, 29, taab199. [Google Scholar] [CrossRef]
  20. de Andrade Pereira Silva, M.; Ribeiro, H.F.; Oliveira, R.R.; Pelloso, F.C.; Pujals, C.; Pedroso, R.B.; Carvalho, M.D.B.; Pelloso, S.M. Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study. PLoS ONE 2022, 17, e0269091. [Google Scholar] [CrossRef]
  21. Khazanchi, R.; Beiter, E.R.; Gondi, S.; Beckman, A.L.; Bilinski, A.; Ganguli, I. County-Level Association of Social Vulnerability with COVID-19 Cases and Deaths in the USA. J. Gen. Intern. Med. 2020, 35, 2784–2787. [Google Scholar] [CrossRef]
  22. Oronce, C.I.A.; Scannell, C.A.; Kawachi, I.; Tsugawa, Y. Association between State-Level Income Inequality and COVID-19 Cases and Mortality in the USA. J. Gen. Intern. Med. 2020, 35, 2791–2793. [Google Scholar] [CrossRef] [PubMed]
  23. Silveira, M.; Fenner, A.L.D. Avaliação de Impactos à Saúde (AIS): Análises e desafios para a Vigilância em Saúde do Brasil. Ciência Saúde Coletiva 2017, 22, 3205–3214. [Google Scholar] [CrossRef] [PubMed]
  24. WHO. World Health Organization: Health Impact Assessment (HIA). The Determinants of Health. 2016. Available online: https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1 (accessed on 29 November 2022).
  25. Takemoto, M.; Menezes, M.O.; Andreucci, C.B.; Knobel, R.; Sousa, L.; Katz, L.; Fonseca, E.B.; Nakamura-Pereira, M.; Magalhães, C.G.; Diniz, C.; et al. Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: A surveillance database analysis. BJOG Int. J. Obstet. Gynaecol. 2020, 127, 1618–1626. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Distribution of treatments performed in the same city where the pregnant women reside. Brazil, 2022.
Figure 1. Distribution of treatments performed in the same city where the pregnant women reside. Brazil, 2022.
Healthcare 11 02072 g001
Figure 2. Number of doctors, nurses and beds per 100,000 inhabitants in each Brazilian state. Brazil, 2022.
Figure 2. Number of doctors, nurses and beds per 100,000 inhabitants in each Brazilian state. Brazil, 2022.
Healthcare 11 02072 g002
Table 1. Descriptive table of clinical and social variables. Brazil, 2022.
Table 1. Descriptive table of clinical and social variables. Brazil, 2022.
Categorical VariablesLevelAbsolute FrequencyRelative Frequency
Gestational age1st trimester254410.79%
2nd trimester587524.92%
3rd trimester13,93959.11%
Not informed12225.18%
RaceWhite807334.79%
Native born1460.63%
Not informed287112.37%
Brown10,55445.48%
Black13705.90%
SettingNot informed23029.76%
Suburban1130.48%
Urban19,59883.11%
Risk factorNo12,48752.96%
Yes11,09347.04%
CardiopathyNo597025.32%
Not informed16,37169.43%
Yes12395.25%
Hematological diseaseNo670628.44%
Not informed16,76071.08%
Yes1140.48%
Down syndromeNo677528.73%
Not informed16,78571.18%
Yes200.08%
Liver diseaseNo671928.49%
Not informed16,80971.28%
Yes520.22%
AsthmaNo604025.61%
Not informed16,45069.76%
Yes10904.62%
DiabetesNo575624.41%
Not informed16,30069,13%
Yes15246.46%
Neurological diseaseNo664828.19%
Not informed16,77771.15%
Yes1550.66%
PneumopathyNo664728.19%
Not informed16,75671.06%
Yes1770.75%
ImmunosupressionNo657427.88%
Not informed16,75371.05%
Yes2531.07%
Renal diseaseNo662628.10%
Not informed16,82171.34%
ObesityYes1330.56%
No606625.73%
Not informed16,55670.21%
Yes9584.06%
Other risk factorsNo21739.22%
Not informed14,13259.93%
Yes727530.85%
VaccineNo709430.08%
Not informed12,53853.17%
Yes394816.74%
Final classificationCOVID-1913,14055.73%
Influenza4411.87%
Not specified975741.38%
Other etiological agent530.22%
Other respiratory virus1890.80%
ICUICU admission414017.55%
VentilationUse of non-invasive ventilatory support607025.74%
Use of invasive ventilatory support16026.79%
OutcomeCure18,77879.64%
Not specified364515.46%
Death10964.65%
Death from other causes610.26%
Numerical Variables MeanStandard Deviation
Age 28.918.41
HDI 0.750.05
Family Health Strategy 3546.263170.10
Illiteracy rate 0.090.05
Per capita income 1187.07439.71
Urbanization rate 0.800.09
Table 2. Poisson regression model adjusted between prevalence of COVID-19 cases in pregnant women and socioeconomic indicators of states, sample size n = 23,580. Brazil, 2022.
Table 2. Poisson regression model adjusted between prevalence of COVID-19 cases in pregnant women and socioeconomic indicators of states, sample size n = 23,580. Brazil, 2022.
VariableStandard Errorp-ValueOdds Ratio
(Intercept)3.93340.2130134.0707
HDI6.38760.40340.0048
Illiteracy2.98520.28900.0422
Per capita income0.00050.25781.0005
Urbanization1.83660.70410.7041
Table 3. Multiple logistic model between risk factors and regional social indicators of pregnant women for the response variables “death”, “ICU admission” and “ventilatory support”, sample size n = 23,580. Brazil, 2022.
Table 3. Multiple logistic model between risk factors and regional social indicators of pregnant women for the response variables “death”, “ICU admission” and “ventilatory support”, sample size n = 23,580. Brazil, 2022.
DeathICU AdmissionVentilatory Support
p-ValueOdds Ratiop-ValueOdds Ratiop-ValueOdds
Ratio
(Intercept)0.58740.09970.25790.03500.99251.0246
White race0.81491.28000.14430.41640.39340.5974
Native born0.98280.00000.08340.12420.04410.1338
Brown race0.60421.72670.15090.41850.57760.7126
Black race0.73961.43690.58960.71250.76520.8283
Cardiopathy0.30731.25390.03341.40900.00571.5210
Hematological disease0.98550.00000.66780.70230.62221.3442
Down syndrome0.17455.33020.46262.46810.72171.6605
Liver disease0.98730.00000.96840.00000.48370.5744
Diabetes0.01791.61630.57530.91390.51351.0962
Neurological disease0.46730.57310.39311.44860.26970.6195
Pneumopathy0.80191.17590.75620.85870.48541.3482
Immunosupression0.22411.77630.74191.13070.11681.7131
Renal disease0.50781.46290.79291.12410.95870.9796
Obesity0.00002.93030.00002.99160.00002.4256
Other comorbidities0.46730.57310.39311.44860.69160.6195
HDI0.90502.51460.592518.27450.69166.5343
Illiteracy0.83840.48850.0279296.69040.06250.0156
Per capita income0.79080.99980.35461.00050.07711.0008
Urbanization0.60630.26300.73720.53870.07140.0567
Age over 35 years0.00021.92790.00501.43900.00001.7218
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ribeiro, H.F.; de Barros Carvalho, M.D.; Pelloso, F.C.; Santos, L.d.; de Andrade Pereira Silva, M.; Stevanato, K.P.; Borghesan, D.H.P.; Romani, I.; Marques, V.D.; de Freitas, K.M.S.; et al. Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil. Healthcare 2023, 11, 2072. https://doi.org/10.3390/healthcare11142072

AMA Style

Ribeiro HF, de Barros Carvalho MD, Pelloso FC, Santos Ld, de Andrade Pereira Silva M, Stevanato KP, Borghesan DHP, Romani I, Marques VD, de Freitas KMS, et al. Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil. Healthcare. 2023; 11(14):2072. https://doi.org/10.3390/healthcare11142072

Chicago/Turabian Style

Ribeiro, Helena Fiats, Maria Dalva de Barros Carvalho, Fernando Castilho Pelloso, Lander dos Santos, Marcela de Andrade Pereira Silva, Kely Paviani Stevanato, Deise Helena Pelloso Borghesan, Isaac Romani, Vlaudimir Dias Marques, Karina Maria Salvatore de Freitas, and et al. 2023. "Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil" Healthcare 11, no. 14: 2072. https://doi.org/10.3390/healthcare11142072

APA Style

Ribeiro, H. F., de Barros Carvalho, M. D., Pelloso, F. C., Santos, L. d., de Andrade Pereira Silva, M., Stevanato, K. P., Borghesan, D. H. P., Romani, I., Marques, V. D., de Freitas, K. M. S., Jacinto Alarcão, A. C., Pujals, C., Bocchi Pedroso, R., Cardelli, A. A. M., & Pelloso, S. M. (2023). Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil. Healthcare, 11(14), 2072. https://doi.org/10.3390/healthcare11142072

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop